Methoxyamine: Phase I started

Tracon began a Phase I trial to evaluate TRC102 in combination with Temodar temozolomide from Schering-Plough Corp. (NYSE:SGP, Kenilworth, N.J.). Tracon licensed exclusive rights to TRC102 from Case...